STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:
Diamyd Medical (NASDAQ:DMYDY) (STO:DIAMB) announced today that the Company has appointed Peter Zerhouni as new Chief Financial Officer.
Peter Zerhouni is currently Director of Business Development at Diamyd Medical. Peter joined the Company in 2006 and had prior to this spent seven years in Brussels and Amsterdam holding various financial positions within ING, one of Europe’s leading banks.
Peter holds a B.Sc. in Economics & Business Administration as well as a M.Sc. in Biology, both from Lund University and Berkeley, California.
